INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 24 filers reported holding INHIBIKASE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $299,000 | -33.3% | 403,000 | +33.0% | 0.01% | -7.1% |
| Q1 2022 | $448,000 | +0.7% | 303,000 | 0.0% | 0.01% | -36.4% |
| Q4 2021 | $445,000 | -22.7% | 303,000 | 0.0% | 0.02% | -50.0% |
| Q3 2021 | $576,000 | -17.7% | 303,000 | +21.2% | 0.04% | +15.8% |
| Q2 2021 | $700,000 | – | 250,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmond Asset Management, LLC | 125,805 | $62,903 | 0.02% |
| Retirement Planning Co of New England, Inc. | 35,212 | $17,606 | 0.01% |
| CCG WEALTH MANAGEMENT, LLC | 30,000 | $15,000 | 0.01% |
| Koshinski Asset Management, Inc. | 65,377 | $32,688 | 0.00% |
| ZEKE CAPITAL ADVISORS, LLC | 93,800 | $46,900 | 0.00% |
| WELLS FARGO & COMPANY/MN | 136 | $68 | 0.00% |
| NORTHERN TRUST CORP | 28,872 | $14,436 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 89,048 | $44 | 0.00% |
| STATE STREET CORP | 121,000 | $60,500 | 0.00% |